Grant RDF
pages:- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- more...
- A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment.....
- A Randomized, Double-Blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohns’s Disease Celgene
- A Randomized, Double-Blind, Parallel Group Study Evaluating the Safety of Fluticasone Propionate/Salmeterol 100/50Mcg Hf
- A Randomized, Double-Blind, Parallel-Group, 12-Week Study Toevaluate the Anti-Inflammatory Effect of Fluticasone Prop...
- A Randomized, Double-Blind, Place-Controlled, Phase 3 Study of the Safety and Efficacy of Pirfenidone in Patients With..
- A Randomized, Double-Blind, Place-Cotrolled, Parallel Group,Stratified, Multicenter, 12 Week Study Comparing the Safety
- A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Amg 531 Treatment of Subjects
- A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Amg 531 Treatment of Subjects
- A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens . . .
- A randomized, double-blind, placebo controlled, five parallel group study of the effect of CP-424, 391 on physical performance and body composition in older subjects
- A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multi Study to Evaluate Efficacy and Safety of 0.65G
- A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis
- A Randomized, Double-Blind, Placebo-Controlled Study of Agi-003(Arverapamil) in the Treatment of Irritable Bowel Syndrom
- A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan)in Control..
- A Randomized, Double-Blind, Placebo-Controlled Study of the Jak Inhibitor Incb018424 Tablets Administered Orally.......
- A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatment-Naïve Adults with Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (SAPPHIRE-I)
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet To.....
- A Randomized, Double-Blind, Placebo-Controlled Trial of Prop Hylactic Heparin in Patients with Severe Sepsis
- A Randomized, Double-Blind, Placebo-Controlled, Dose- Escalation Study of Nnz-2566 in Patients With Traumatic . .
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE PREVENTION OF COMPLICATIONS IN SUBJECTS WITH EARLY DECOMPENSATED LIVER CIRRHOSIS
- A Randomized, Double-Blind, Placebo-Controlled, Event-Drivenmulticenter Study to Evaluate the Efficacy and Safety of Riv
- A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Evaluate Efficacy and Safety of Pramipexole...
- A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa in Initiated At 40,000 Iu Ever
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Regn475 In.......
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety .....
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study to Investigate the Safety......
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Effects of Repeated Doses of
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group...to Evaluate the Efficacy and Safety of Ad5Fgf-4
- A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Multicenter Study Comparing an Eight-Week Treatment..
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects with Coronary Artery Disease using Intravascular Ultrasound (IVUS) ACTIVATE Study